{
    "medicine_id": "9f85a9bf1a494a08e9be3b52d7a564e807c4fc21",
    "platform_id": "DB05493",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v NX 1207",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in benign prostatic hyperplasia",
            "contraindications": {
                "disease": "The results of the trial demonstrated the excellent safety and side effect profile of NX 1207 In particular patients given NX 1207 had no 0 significant sexual side effects",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NX 1207 is an investigational new drug for BPH whose chemical entity and mechanism of action remain undisclosed BPH is a common disorder of older men afflicting approximately half of men over age 50 and close to 90 of men by age 80 The disorder causes difficulties with urination associated with aging such as urination at night urge to void frequently hesitancy weak stream and other problems",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}